EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Establishment and Validation of a Prognostic Model for 28‐Day Mortality Incorporating Inflammatory Mediators and Organ Function Indicators in Patients With Sepsis: A Retrospective Multicenter Study

Meng-Xiao Feng, Cong-Ying Song, Wei Huang, Jin-Min Chen, Zheng Zhang, Zhi-Yuan Fan, Yuan-Qiang Lu

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/5567993 ↗
AbstractBibliografische Angaben

Abstract

Background Conventional prognostic markers have limited discriminative power for mortality prediction in septic patients. Building on the fact that dysregulated inflammatory responses are central to sepsis pathophysiology, this study aimed to establish and validate a novel prognostic model incorporating inflammatory mediator‐related and organ function‐related indicators to predict 28‐day mortality in septic patients. Methods This retrospective multicenter study enrolled 200 eligible septic patients from January 2019 to April 2022. The primary outcome was defined as 28‐day all‐cause mortality. The patients were randomized into training dataset ( n = 140) and validation dataset ( n = 60) at a ratio of 7:3. A comprehensive set of clinical and laboratory parameters, including organ‐related indicators and inflammatory mediators, was systematically collected. The risk factors for predicting death were selected using the least absolute shrinkage and selection operator (LASSO) logistic regression and the binary logistics regression analysis. The receiver operating characteristic (ROC) curve was drawn to determine the model discrimination. Model performance was further evaluated by calibration curves, decision curve analysis, and clinical impact curve. Results The training dataset included 110 survivors and 30 nonsurvivors. After a multistep screening process, the prognostic factors in the nomogram included aspartate aminotransferase (AST), the logarithmic form of interleukin (IL)‐6, and interferon (IFN)‐γ with base 10. The model exhibited a good predictive power for death with an area under the curve of 0.889 (95% confidence interval [CI]: 0.808–0.970) in the training dataset and 0.808 (95% CI: 0.690–0.925) in the validation dataset. The calibration curves showed a good agreement between the predicted and actual probabilities. Both decision curve analysis and clinical impact curve analysis suggested potential clinical utility. Conclusion The prognostic model developed and internally validated in this study incorporates AST and two inflammatory mediators, IL‐6 and IFN‐γ, which demonstrated good discriminative performance in predicting 28‐day mortality among septic patients. The findings suggest that inflammatory mediator‐related variables, when combined with an organ function‐related indicator, may facilitate early risk stratification and provide complementary prognostic information for clinical decision‐making.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →